Gracecast Lung Cancer Audio

Q and A Session with Drs. Ben Solomon and Ross Camidge on ALK Inhibition for Advanced NSCLC (audio)

Informações:

Sinopsis

Drs. Ben Solomon (Peter MacCallum Cancer Center in Melbourne) and Ross Camidge (Univ. of Colorado) answer Qs on ALK rearrangements and crizotinib (XALKORI) for advanced non-small cell lung cancer (NSCLC).